Home » Topics » Regulatory » Patents

Patents
RSS

New cysteine protease inhibitors from SB for osteoporosis, arthritis, etc.

Jan. 13, 1999

Quinazolinones as farnesyltransferase inhibitors in early development at Janssen

Jan. 12, 1999

Preparation and use of new class of tachykinin antagonists disclosed by MS&D

Jan. 12, 1999

Spanish university research team discovers new alkaloids with antitumor properties

Jan. 12, 1999

Max Planck reports cysteine-containing compounds as MMP inhibitors

Jan. 12, 1999

Series of Na+/H+ exchange inhibitors developed at Toa Eiyo

Jan. 12, 1999

Shionogi patents water-soluble inhibitors of human sPLA2

Jan. 12, 1999

Orally bioavailable agents for vascular wall hypertrophy described by Kissei

Jan. 12, 1999

Eisai prepares novel digalactosylceramide derivatives for multiple indications

Jan. 11, 1999

Physiologically active brain natriuretic peptides disclosed by Daiichi

Jan. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...